The estimated Net Worth of James Corbett is at least $130 Thousand dollars as of 26 December 2023. James Corbett owns over 1,445 units of AVITA Medical Inc stock worth over $110,821 and over the last 10 years James sold RCEL stock worth over $19,204.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
James Corbett RCEL stock SEC Form 4 insiders trading
James has made over 3 trades of the AVITA Medical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently James sold 1,445 units of RCEL stock worth $19,204 on 26 December 2023.
The largest trade James's ever made was buying 34,000 units of AVITA Medical Inc stock on 10 August 2015 worth over $24,480. On average, James trades about 5,037 units every 293 days since 2014. As of 26 December 2023 James still owns at least 11,580 units of AVITA Medical Inc stock.
You can see the complete history of James Corbett stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's James Corbett's mailing address?
James's mailing address filed with the SEC is 28159 AVENUE STANFORD, SUITE 220 - AVITA MEDICAL, VALENCIA, CA, 91355.
Insiders trading at AVITA Medical Inc
Over the last 5 years, insiders at AVITA Medical Inc have traded over $2,850,472 worth of AVITA Medical Inc stock and bought 19,459 units worth $293,310 . The most active insiders traders include Michael S Perry, James Corbett, and David D O'toole. On average, AVITA Medical Inc executives and independent directors trade stock every 82 days with the average trade being worth of $135,636. The most recent stock trade was executed by David D O'toole on 30 May 2024, trading 1,000 units of RCEL stock currently worth $8,900.
What does AVITA Medical Inc do?
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
What does AVITA Medical Inc's logo look like?
Complete history of James Corbett stock trades at Alphatec Inc and AVITA Medical Inc
AVITA Medical Inc executives and stock owners
AVITA Medical Inc executives and other stock owners filed with the SEC include:
-
Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D.,
CEO, Pres & Exec. Director -
Erin Liberto,
Chief Commercial Officer -
Andrew Quick,
Chief Technology Officer -
Donna Shiroma,
Gen. Counsel & Sec. -
Michael Bria Holder MBA,
Chief Financial Officer -
Kathy M. McGee,
Chief Operating Officer -
Debbie Garner,
VP of Global Marketing -
David Fencil,
VP of Global Operations -
Sean Ekins,
Interim CFO -
Donna Shiroma,
General Counsel -
David Mc Intyre,
Chief Financial Officer -
Erin Liberto,
Chief Commercial Officer -
David D O'toole,
CFO -
Suzanne Crowe,
-
James Corbett,
CEO -
Kathy M. Mc Gee,
Chief Operating Officer -
Michael Holder,
Chief Financial Officer -
Lou Panaccio,
-
Louis Drapeau,
Director -
Jeremy Curnock Cook,
-
Michael S Perry,
Director -
Cary Guy Vance,
-
Robert Mc Namara,
-
Jan Stern Reed,